Global Pharmaceuticals Industry Profile & Value Chain Analysis

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

The value/supply chain analysis reveals the business activities which comprise the global pharmaceuticals market’s value/supply chain. All key stages are highlighted, along with examples of companies active, and assessments of the burning issues for every stage of the value/supply chain. Key value/supply chain stages analyzed include raw ingredients, manufacturing, buyers and end-users.

Synopsis

Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

– The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.

– The global pharmaceuticals market had total revenues of $946.1bn in 2016, representing a compound annual growth rate (CAGR) of 6.1% between 2012 and 2016.

– The US, Japan and China are the largest global pharmaceutical markets followed by the four biggest European markets: France, Germany, the UK, and Italy. Amongst that number it is China that is producing the strongest growth every year, whilst the European states have been stifled due to current healthcare spending cultures in the region.

– The patent cliff has caused revenue losses for many companies. The sales of Pfizer, Novartis and Merck & Co. fell when they lost their patents for Lipitor, Diovan and Singulair, respectively. AstraZeneca has been particularly affected by the patent cliff.

– Raw ingredients in pharmaceuticals are very wide-ranging in scope but can be loosely combined into groups. Pharmaceutical companies are responsible for sourcing ingredients.

– Manufacturing of pharmaceutical drugs is typically undertaken by large, international pharmaceutical companies.

– Health care providers make the majority of pharmaceutical purchases, but pharmacies and retailers remain important buyers for pharmaceutical companies.

Scope

– Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market

– Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

– Quickly and easily identify the key stages and sub-stages of the global pharmaceuticals market value/supply chain

– See examples of companies active at each stage of the global pharmaceuticals market value/supply chain

– Examine trends and burning issues impacting the global pharmaceuticals market value/supply chain

Reasons to buy

- What was the size of the global pharmaceuticals market by value in 2016?

- What will be the size of the global pharmaceuticals market in 2021?

- What factors are affecting the strength of competition in the global pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitors in the global pharmaceuticals market?

- What are the key stages of the global pharmaceuticals market value/supply chain?

Table of Contents

Table of Contents

Executive Summary 2

Value chain analysis 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Value Chain Analysis 7

Pharmaceuticals Market complete value chain overview 7

Raw Ingredients 9

Manufacturing 11

Buyers 13

End-Users 15

Market Overview 17

Market definition 17

Market analysis 17

Market Data 19

Market value 19

Market Segmentation 20

Geography segmentation 20

Market share 21

Market Outlook 22

Market value forecast 22

Five Forces Analysis 23

Summary 23

Buyer power 25

Supplier power 27

New entrants 28

Threat of substitutes 30

Degree of rivalry 31

Leading Companies 32

Bayer AG 32

Johnson & Johnson 36

Novartis AG 39

Pfizer Inc. 42

Methodology 45

Industry associations 46

Related MarketLine research 46

Appendix 47

About MarketLine 47

List of Tables

List of Tables

Table 1: Global pharmaceuticals market value: $ billion, 2012-16 19

Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2016 20

Table 3: Global pharmaceuticals market share: % share, by value, 2016 21

Table 4: Global pharmaceuticals market value forecast: $ billion, 2016-21 22

Table 5: Bayer AG: key facts 32

Table 6: Bayer AG: key financials ($) 33

Table 7: Bayer AG: key financials (€) 33

Table 8: Bayer AG: key financial ratios 34

Table 9: Johnson & Johnson: key facts 36

Table 10: Johnson & Johnson: key financials ($) 37

Table 11: Johnson & Johnson: key financial ratios 37

Table 12: Novartis AG: key facts 39

Table 13: Novartis AG: key financials ($) 40

Table 14: Novartis AG: key financial ratios 40

Table 15: Pfizer Inc.: key facts 42

Table 16: Pfizer Inc.: key financials ($) 43

Table 17: Pfizer Inc.: key financial ratios 43

List of Figures

List fo Figures

Figure 1: Pharmaceuticals Market complete value chain overview 7

Figure 2: Pharmaceuticals Market complete value chain with active companies 8

Figure 3: Raw Ingredients – Overview 9

Figure 4: Manufacturing – Overview 11

Figure 5: Buyers – Overview 13

Figure 6: End-Users – Overview 15

Figure 7: Global pharmaceuticals market value: $ billion, 2012-16 19

Figure 8: Global pharmaceuticals market geography segmentation: % share, by value, 2016 20

Figure 9: Global pharmaceuticals market share: % share, by value, 2016 21

Figure 10: Global pharmaceuticals market value forecast: $ billion, 2016-21 22

Figure 11: Forces driving competition in the global pharmaceuticals market, 2016 23

Figure 12: Drivers of buyer power in the global pharmaceuticals market, 2016 25

Figure 13: Drivers of supplier power in the global pharmaceuticals market, 2016 27

Figure 14: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2016 28

Figure 15: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2016 30

Figure 16: Drivers of degree of rivalry in the global pharmaceuticals market, 2016 31

Figure 17: Bayer AG: revenues & profitability 34

Figure 18: Bayer AG: assets & liabilities 35

Figure 19: Johnson & Johnson: revenues & profitability 38

Figure 20: Johnson & Johnson: assets & liabilities 38

Figure 21: Novartis AG: revenues & profitability 40

Figure 22: Novartis AG: assets & liabilities 41

Figure 23: Pfizer Inc.: revenues & profitability 43

Figure 24: Pfizer Inc.: assets & liabilities 44

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports